Neurodyn Inc. announced today that it has acquired from Galantos Pharma GmbH, Mainz, Germany (galantos.com) all assets related to their Alzheimer’s prescription drug candidate – Memogain®.
Neurodyn Inc. Acquires Memogain® For Dementia in Alzheimer’s Disease
This entry was posted in Mertzholdings News. Bookmark the permalink.